Reprogramming of mouse bone marrow mesenchymal stem cells, mouse bone marrow mononuclear cells and mouse embryonic fibroblasts into induced pluripotent stem cells: a comparison of efficiencies

2014 ◽  
Vol 33 (12) ◽  
pp. 1304-1311
Author(s):  
Yao WANG ◽  
Lei WANG ◽  
Yu-hua LU ◽  
Xiang-jun FAN ◽  
Ming-yan ZHU ◽  
...  
Keyword(s):  
Stem Cells ◽  
Bone Marrow ◽  
Pluripotent Stem Cells ◽  
Mononuclear Cells ◽  
Mouse Bone Marrow ◽  
Bone Marrow Mononuclear Cells ◽  
Mouse Embryonic Fibroblasts ◽  
Embryonic Fibroblasts ◽  
Marrow Mesenchymal Stem Cells ◽  
Induced Pluripotent

scholarly journals Recent Advances in Cell-Based Therapies for Ischemic Stroke

2020 ◽  
Vol 21 (18) ◽  
pp. 6718
Author(s):  
Satoshi Suda ◽  
Chikako Nito ◽  
Shoji Yokobori ◽  
Yuki Sakamoto ◽  
Masataka Nakajima ◽  
...  
Keyword(s):  
Stem Cells ◽  
Bone Marrow ◽  
Pluripotent Stem Cells ◽  
Neurological Disorders ◽  
Causes Of Death ◽  
Mononuclear Cells ◽  
Neurological Outcomes ◽  
Cell Based Therapy ◽  
Recent Advances ◽  
Marrow Mesenchymal Stem Cells

Stroke is the most prevalent cardiovascular disease worldwide, and is still one of the leading causes of death and disability. Stem cell-based therapy is actively being investigated as a new potential treatment for certain neurological disorders, including stroke. Various types of cells, including bone marrow mononuclear cells, bone marrow mesenchymal stem cells, dental pulp stem cells, neural stem cells, inducible pluripotent stem cells, and genetically modified stem cells have been found to improve neurological outcomes in animal models of stroke, and there are some ongoing clinical trials assessing their efficacy in humans. In this review, we aim to summarize the recent advances in cell-based therapies to treat stroke.

Sign in / Sign up

Export Citation Format

Share Document